Thursday, 22 August 2019

Australia News

  • CSL hemophilia therapy gets orphan drug status

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

  • Genetic Technologies Announces Key Managerial Appointment

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Genetic Technologies announced the appointment of Mr. Mark Ostrowski as Senior Vice President Sales and Marketing Molecular Diagnostics. In this role, Mark will be responsible...Read more

  • IMCD acquires Aussie pharma distributor

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered speciality ingredients distributor focused on the nutraceuticals, personal ...Read more

  • Bionomics, CTx advance in growth factor research

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept milestone in the discover...Read more

  • Ansell Completes Acquisition of Comasec SAS

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Ansell, global leader in protective solutions, has successfully concluded its acquisition of Comasec SAS, having received regulatory approval for the transaction. The deal is va...Read more

  • Commercialisation Australia grants $1 mn to Proteomics

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

    Singapore: Commercialisation Australia has awarded Proteomics International, a life sciences company based in Perth, with $1 million grant to develop its biomarkers for diabetic kidney dise...Read more

  • Vaccines do not cause autism: Study

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

    Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childhood vaccination programs. In a study that covered more than 1.25 milli...Read more

  • Cancer researcher gets Aus academy's highest accolade

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Singapore: Cancer researcher Professor Jerry Adams has won the Australian Academy of Science's most prestigious award for biological sciences, the Macfarlane Burnet Medal. Joint head of th...Read more

  • Aussie drug delivery firm raises $19.3 mn

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and A...Read more

  • AusBiotech, Hong Kong firm to partner on investment events

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Biotechnology industry group, AusBiotech and Beacon Events, organiser of the largest resource sector investor event in the Asia Pacific Region called Mines and Money, announced a...Read more

  • University of Sydney makes big takeover

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2014

    Singapore: In a bid to ahead a major initiative towards the advancement of fertility research and treatment, the University of Sydney has announced a big take over. It said in an official s...Read more

  • PolyActiva raises US$9.4 mn in Series B venture funding

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: PolyActiva announced today that it has raised US$9.4 million (AU$9.2 million) in a Series B financing round from a consortium of investors including Medical Research Commercialis...Read more

  • Viralytics gets positive prelim data for Cavatak

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

    Singapore: Viralytics, a company listed in the Australian Securities Exchange, has received positive preliminary data in bladder cancer in its collaboration with Professor Hardev Pandha's ...Read more

  • Starpharma's formulation shows improvement in crop protection

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Starpharma Holdings announced that its new agrochemical dendrimer formulations have shown further improved features compared to commercially available products. Starpharma has ...Read more

  • New South Wales gets Medical Devices Fund

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: New South Wales (NSW) Health and Medical Research Strategic Review has established Medical Devices Fund (MDF) of $5 million per annum to contribute to the discovery and applicati...Read more

  • Ansell, Ramsay enter global purchasing agreement

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australia-based healthcare safety solutions provider, Ansell, entered into a multi-year purchasing agreement with Ramsay Health Care, one of the largest private hospital groups i...Read more

  • Algae.Tec biofuels technology to feature at 2012 ILA Berlin airshow

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Sourcing sustainable aviation biofuels at-scale is a major theme at this year's ILA Berlin Airshow and its dedicated Alternative Aviation Fuels Pavilion, designed to showcase th...Read more

  • Science Academy welcomes biomedical research commitment

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The Australian Academy of Science has welcomed the Federal Government's announcement of the medical research grants awarded by the National Health and Medical Research Council fo...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls